What are the indications, contraindications, mechanism of action, modes, monitoring parameters, and how should bilevel positive airway pressure (BiPAP) be adjusted for different pathologies?

BiPAP: Comprehensive Clinical Guide

Mechanism of Action

BiPAP (Bilevel Positive Airway Pressure) delivers two distinct pressure levels—a higher inspiratory positive airway pressure (IPAP) during inspiration and a lower expiratory positive airway pressure (EPAP) during expiration. 1 The pressure difference between IPAP and EPAP (pressure support = IPAP - EPAP) augments tidal volume and reduces work of breathing, while EPAP maintains upper airway patency, recruits underventilated lung units, offsets intrinsic PEEP, and facilitates CO2 clearance from the mask and circuit. 1

• The EPAP component functions similarly to PEEP in invasive ventilation, preventing alveolar collapse and improving oxygenation. 1
• In COPD patients with dynamic hyperinflation, EPAP counteracts intrinsic PEEP, reducing inspiratory work and potentially lowering PaCO2. 1
• BiPAP is pressure-targeted rather than volume-targeted, making it more leak-tolerant and comfortable for mask interfaces compared to volume ventilators. 1

Indications

Primary Indications (Strong Evidence)

BiPAP should be used in patients with acute exacerbation of COPD who develop respiratory acidosis (pH <7.35) despite maximal medical therapy on controlled oxygen. 1 This represents the strongest indication with Level A evidence.

BiPAP is indicated for acute or acute-on-chronic hypercapnic respiratory failure due to chest wall deformity or neuromuscular disease. 1

In patients with decompensated obstructive sleep apnea presenting with respiratory acidosis, BiPAP should be used rather than CPAP alone. 1

Secondary Indications

• Type 2 respiratory failure with poor respiratory drive where patients cannot maintain adequate spontaneous breathing—BiPAP with backup rate is required rather than CPAP. 1
• Chronic alveolar hypoventilation syndromes including obesity hypoventilation syndrome, restrictive lung diseases, and neuromuscular disorders requiring nocturnal ventilatory support. 1, 2
• Acute exacerbation of bronchiectasis with respiratory acidosis (pH <7.35), though excessive secretions may limit effectiveness. 1
• Cardiogenic pulmonary edema when CPAP alone is unsuccessful in correcting hypoxemia or when hypercapnia develops. 1
• Weaning from invasive ventilation when conventional weaning strategies fail. 1

Conditional Use (Requires ICU/HDU Setting)

• Diffuse pneumonia with hypercapnia in patients who are intubation candidates if BiPAP fails. 1
• Post-extubation respiratory failure (evidence conflicting—some guidelines suggest benefit, others show no advantage). 1

Absolute Contraindications

BiPAP must be withheld in patients with pneumothorax for the entire duration the pneumothorax is present, regardless of size. 1 This is a critical safety recommendation.

Do not use BiPAP in the following situations: 1

• Recent facial or upper airway surgery
• Facial burns or trauma
• Fixed upper airway obstruction
• Active vomiting
• Recent upper gastrointestinal surgery
• Inability to protect airway

Relative Contraindications

• Excessive respiratory secretions that cannot be cleared (particularly relevant in bronchiectasis). 1
• Hemodynamic instability requiring immediate intubation
• Impaired consciousness or inability to cooperate (unless in controlled setting with close monitoring)
• Acute asthma (BiPAP should not be used routinely). 1

Modes of Operation

Spontaneous Mode (S)

The patient controls both respiratory rate and inspiratory time within device limits. 1 The ventilator cycles from EPAP to IPAP based on patient-triggered breaths only. If the patient fails to trigger, no ventilatory support is delivered.

• Use in patients with intact respiratory drive and adequate spontaneous breathing effort. 1

Spontaneous-Timed Mode (ST)

ST mode provides a backup respiratory rate to ensure minimum ventilation if the patient fails to trigger breaths within a set time window. 1 For example, with a backup rate of 10 bpm, if no spontaneous breath occurs within 6 seconds, the device delivers a machine-triggered breath.

ST mode should be used in: 1

• All patients with central hypoventilation
• Patients with significant central apneas or inappropriately low respiratory rate
• Patients who unreliably trigger IPAP/EPAP cycles due to muscle weakness
• When adequate ventilation or respiratory muscle rest is not achieved with maximum tolerated pressure support in spontaneous mode

Timed Mode (T)

The ventilator delivers breaths at a fixed respiratory rate with set inspiratory time, independent of patient effort. 1

• Use when ST mode fails to meet titration goals. 1
• Appropriate for patients with minimal or absent respiratory drive. 1

Initial Settings and Titration

Starting Parameters

Recommended minimum starting pressures: IPAP 8 cmH2O, EPAP 4 cmH2O. 1

Recommended maximum IPAP: 1

• Adults and children ≥12 years: 30 cmH2O
• Children <12 years: 20 cmH2O

Pressure support (PS = IPAP - EPAP) range: minimum 4 cmH2O, maximum 20 cmH2O. 1

Backup Rate Settings (for ST or T modes)

Starting backup rate should equal or be slightly less than the spontaneous sleeping respiratory rate, with a minimum of 10 bpm. 1

Increase backup rate in 1-2 bpm increments every 10 minutes if goals are not met. 1

Set IPAP time (inspiratory time) to 30-40% of cycle time (60/respiratory rate in bpm). 1

Interface Selection

Full-face masks are the most suitable interface for acute hypercapnic respiratory failure, as mouth breathing predominates. 1 After 24 hours, as the patient improves, consider changing to a nasal mask. 1

• Have multiple mask sizes and types available (nasal, oronasal, nasal pillows) in both adult and pediatric sizes. 1
• Ensure proper mask fitting with acclimatization period at low pressure before full titration. 1

Monitoring Parameters

Essential Monitoring

Monitor the following continuously during BiPAP use: 1

• Airflow signal (to detect apneas and hypopneas)
• Tidal volume and respiratory rate (to assess ventilation adequacy)
• Delivered pressure and leak
• SpO2 continuously
• Transcutaneous or end-tidal PCO2 (if available and validated with arterial blood gas)

Target Values

SpO2 targets: 1

• General target: 90-96%
• Patients with strong respiratory drive (low/normal PaCO2): ≥94%
• Patients with acute or chronic type 2 respiratory failure: 88-92%
• Pregnant patients: 92-95%

PCO2 goal: ≤ awake PCO2 value. 1

Critical Timing for Assessment

Patients must be closely monitored and their condition evaluated within 1-2 hours after initiating BiPAP. 1 If no improvement or worsening occurs, proceed immediately to intubation to avoid delayed intubation and worse outcomes.

Pathology-Specific Adjustments

COPD with Acute Hypercapnic Respiratory Failure

Titration algorithm: 1

1. Start with IPAP 8 cmH2O, EPAP 4 cmH2O
2. Increase IPAP and/or EPAP to eliminate obstructive events (apneas, hypopneas, RERAs, snoring) using standard CPAP titration principles
3. Increase pressure support (PS) every 5 minutes if:
   • Tidal volume remains low (<6-8 mL/kg)
   • PCO2 remains ≥10 mmHg above goal for ≥10 minutes
   • SpO2 <90% for ≥5 minutes with low tidal volume
4. Add ST mode with backup rate if: 1
   • Central apneas develop
   • Respiratory rate becomes inappropriately low
   • Maximum tolerated PS in spontaneous mode fails to achieve adequate ventilation
5. Target SpO2 88-92% in patients with chronic type 2 respiratory failure 1

Neuromuscular Disease and Restrictive Disorders

These patients require ST mode as first-line due to muscle weakness and unreliable triggering. 1

Titration approach: 1

1. Start IPAP 8 cmH2O, EPAP 4 cmH2O with backup rate 10 bpm
2. Increase PS to achieve tidal volume 6-8 mL/kg
3. Increase PS if respiratory muscle rest not achieved (assess via reduction in diaphragmatic EMG activity if available)
4. Adjust backup rate upward if spontaneous rate inadequate
5. Consider mouthpiece ventilation (MPV) as adjunct for daytime use to avoid or delay tracheostomy 1
6. Transition to invasive ventilation via tracheostomy if unable to clear secretions, mental status changes occur, or 24-hour NIV becomes necessary 1

Obesity Hypoventilation Syndrome

Use ST mode with higher pressure support requirements. 1

1. Start with higher initial pressures (IPAP 10-12 cmH2O, EPAP 6-8 cmH2O) due to increased chest wall impedance
2. Titrate PS aggressively to achieve adequate tidal volumes (often requires PS >10 cmH2O)
3. Set backup rate 12-15 bpm as these patients often have blunted respiratory drive
4. Target SpO2 >90% 1

Cardiogenic Pulmonary Edema

CPAP is first-line; reserve BiPAP for CPAP failure or development of hypercapnia. 1

If BiPAP required: 1

1. Start CPAP 10 cmH2O with FiO2 0.6 if patient oriented and tolerates mask
2. If escalation needed, increase to CPAP 12-15 cmH2O with FiO2 0.6-1.0
3. Convert to BiPAP only if hypercapnia develops or patient cannot tolerate high CPAP levels
4. Use minimal PS (4-6 cmH2O) to avoid excessive reduction in preload
5. Target SpO2 ≥94% 1

Post-Pneumothorax Management

After pneumothorax resolution, avoid the following for 2 weeks: 1

• Air travel
• Lifting weights >5 pounds
• Spirometry
• BiPAP use (if previously on BiPAP, withhold until 2 weeks post-resolution)

Supplemental Oxygen

Add supplemental oxygen when: 1

• Awake SpO2 <88%, OR
• PS and respiratory rate optimized but SpO2 remains <90% for ≥5 minutes

Start at minimum 1 L/min and titrate upward. 1

Caution: In COPD patients, maintain target SpO2 88-92% to avoid suppression of hypoxic drive. 1

Common Pitfalls and Troubleshooting

Worsening Hypercapnia Despite BiPAP

Check for: 1

• Exhaust port occlusion (by sputum or malposition)—this causes rebreathing and CO2 retention
• Inadequate EPAP (minimum 3-5 cmH2O needed to vent exhaled air in single-limb circuits)
• Excessive leak compromising delivered tidal volume
• Insufficient pressure support—increase PS incrementally

Patient-Ventilator Asynchrony

• Increase IPAP time if patient appears to be "fighting" the ventilator during inspiration
• Adjust trigger sensitivity if auto-triggering or failure to trigger occurs
• Consider switching from S to ST mode if patient has irregular breathing pattern

Mask Leak and Discomfort

• Try different mask sizes and types before abandoning BiPAP 1
• Use heated humidification to improve comfort and compliance 2
• Allow acclimatization period at low pressures before full titration 1

Gastric Distension

• Occurs more commonly with high IPAP levels (>20 cmH2O)
• Consider reducing IPAP if tolerated or switching to volume-targeted ventilation in severe cases

Equipment Requirements

Essential equipment for BiPAP setup: 1

• BiPAP device capable of S, ST, and T modes
• Ability to monitor and record airflow, tidal volume, leak, and delivered pressure
• Multiple mask types and sizes (nasal, oronasal, nasal pillows) in adult and pediatric sizes
• Supplemental oxygen source
• Heated humidification
• Transcutaneous or end-tidal PCO2 monitoring (ideally validated with arterial blood gas)

Follow-Up and Long-Term Management

For chronic BiPAP users: 2

• Initial follow-up within first few weeks to establish utilization pattern and address problems
• Objective monitoring of usage (download device data)
• Yearly follow-up minimum or as needed for mask, machine, or usage issues
• Systematic educational program to improve compliance
• Polysomnography to confirm effectiveness if settings were initiated empirically without sleep study 1